IDEAYA Biosciences宣布其临床试验成功达到主要研究终点。经独立中心影像评估确认,该研究在主要疗效指标——中位无进展生存期方面展现出具有统计学意义的显著改善。
这一突破性进展标志着公司在靶向疗法开发领域取得重要里程碑,为后续临床开发计划的推进奠定了坚实基础。
IDEAYA Biosciences宣布其临床试验成功达到主要研究终点。经独立中心影像评估确认,该研究在主要疗效指标——中位无进展生存期方面展现出具有统计学意义的显著改善。
这一突破性进展标志着公司在靶向疗法开发领域取得重要里程碑,为后续临床开发计划的推进奠定了坚实基础。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.